Moreover, inhibition of AR, one of the treatments for PCa, can enhance the expression of NK1R, thereby stimulating the protein kinase C (PKC)/AURKA/N-MYC pathway in PCa cells. This evidence concerns the gene AURKA and posterior cortical atrophy.